Heart and Liver Stiffness Study Using Advanced Ultrasound for Heart Failure Patients

This important clinical research study is exploring new ways to measure heart and liver stiffness in patients with specific types of heart failure. The study focuses on heart failure patients who have preserved or mildly reduced heart pumping function, along with a condition called left ventricular hypertrophy where the heart muscle becomes thickened. Researchers are particularly interested in comparing patients with and without a rare condition called transthyretin amyloid cardiomyopathy (ATTR-CM), where abnormal proteins build up in the heart tissue.

The study uses a specialized ultrasound device called eMyosound LYRA that can measure tissue stiffness through a technique called shear wave elastography. This non-invasive method is similar to a standard echocardiogram but provides additional information about how stiff the heart muscle and liver tissues have become. Stiffness measurements are important because they can indicate how advanced heart failure has become and help doctors understand the underlying causes of the condition.

Participants in this study will attend a single visit lasting approximately 2.5 hours at one of three leading medical centers: Massachusetts General Hospital, Brigham and Women's Hospital, or Boston Medical Center. During this visit, patients will undergo comprehensive heart assessments including a medical history review, physical examination, electrocardiogram (ECG), blood tests, and standard echocardiogram. The innovative part involves the additional elastography measurements that will be taken from specific areas of the heart and liver using the specialized ultrasound device.

The research aims to enroll 150 participants divided into three groups: heart failure patients with ATTR-CM, heart failure patients without ATTR-CM, and a control group of healthy volunteers without heart conditions. All participants must be 60 years or older, and the study is specifically looking for people who have heart failure with preserved ejection fraction (when the heart pumps normally but has trouble relaxing) or mildly reduced ejection fraction.

This research is significant because current methods for assessing heart stiffness often require invasive procedures or advanced imaging that may not be widely available. If successful, this ultrasound technique could provide doctors with a simpler, non-invasive way to monitor heart failure progression and treatment effectiveness. The study will also help establish normal ranges for tissue stiffness measurements and determine how reliable these measurements are when taken by different healthcare providers.

For patients and caregivers, understanding tissue stiffness is crucial because it relates directly to symptoms like shortness of breath, fatigue, and fluid retention that many heart failure patients experience. As heart muscle becomes stiffer, it has more difficulty filling with blood between beats, leading to these common symptoms. Similarly, liver stiffness can indicate congestion from heart failure, providing important clues about how the condition is affecting other organs.

The safety profile of this study is excellent, as the procedures involved are similar to standard echocardiograms that millions of patients undergo safely each year. Participants benefit from receiving a thorough cardiac evaluation at no cost, which can provide valuable information about their heart health. The study includes careful monitoring by a independent safety board to ensure participant wellbeing throughout the research process.

Heart failure research continues to be critically important as this condition affects millions of people worldwide and significantly impacts quality of life. Studies like this one that explore new diagnostic techniques help move the field forward by providing doctors with better tools to understand and manage complex heart conditions. Early and accurate assessment of heart stiffness could lead to more personalized treatments and better outcomes for patients living with heart failure.

Clinical research in cardiology has transformed how we understand and treat heart conditions over recent decades. From the development of medications that prolong life to minimally invasive procedures that restore heart function, research continues to drive improvements in patient care. This study represents the next frontier in heart failure management – using advanced imaging technology to detect subtle changes in heart tissue that traditional methods might miss.

For patients considering participation, this study offers an opportunity to contribute to medical knowledge that could benefit countless others with similar conditions. The single-visit design makes participation convenient, and the comprehensive cardiac assessment provides valuable health information. As with all clinical research, participation is completely voluntary, and patients can withdraw at any time without affecting their standard medical care.